【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-057195 Size: 5 KB 网页链接
$Neuronetics(STIM)$ 3/A [Amend] Initial statement of beneficial ownership of securities Accession Number: 0001209191-19-057193 Size: 3 KB 网页链接
$Neuronetics(STIM)$ 内部交易: 2019-11-18,Director,Farley Brian E ,买入,11000普通股, $4.27
$Neuronetics(STIM)$ 内部交易: 2019-11-14,Director,Farley Brian E ,买入,19000普通股, $4.60
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-057051 Size: 6 KB 网页链接
$Neuronetics(STIM)$ 8-K - Current report Filed: 2019-11-05 AccNo: 0001564590-19-040062 Size: 560 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Neuronetics(STIM)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-05 AccNo: 0001564590-19-040392 Size: 10 MB 网页链接
$Neuronetics(STIM)$ 8-K - Current report Filed: 2019-11-01 AccNo: 0001193125-19-281172 Size: 38 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 8.01: Other Event...
$Neuronetics(STIM)$ EFFECT - Notice of Effectiveness Filed: 2019-08-15 AccNo: 9999999995-19-001894 Size: 1 KB 网页链接
$Neuronetics(STIM)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001564590-19-028991 Size: 563 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接